• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Resolution Pharmaceuticals inks deals

Article

Radiopharmaceutical developer Resolution Pharmaceuti-cals of Mississauga,Ontario, has entered into two R&D collaborations with Canadianinstitutes to develop new imaging agents. Both deals have thesupport of Canadian research agencies. In the first

Radiopharmaceutical developer Resolution Pharmaceuti-cals of Mississauga,Ontario, has entered into two R&D collaborations with Canadianinstitutes to develop new imaging agents. Both deals have thesupport of Canadian research agencies.

In the first deal, Resolution and the Alberta Peptide Institutewill receive up to $200,000 from the National Research Council'sIndustrial Research Assistance Program to investigate new radiopharmaceuticalsto image bacterial and fungal infections.

In the second deal, Resolution and the Ontario Cancer Centerreceived a $50,000 grant from the Medical Research Council ofCanada to research compounds to be used in functional medicalimaging that could also be used to aid disease treatment suchas chemotherapy.

Resolution Pharmaceuticals is a joint venture between Canadianradioisotope producer Nordion International and Allelix Biopharmaceuticals.The company's peptide-based radiopharmaceutical for imaging inflammatorydisease completed phase I clinical testing earlier this year (SCAN1/17/96).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.